✦ LIBER ✦

P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease

✍ Scribed by B. Jarraya; H. Lepetit; S. Ralph; S. Boulet; C. Jan; G. Bonvento; J. Miskin; J.-M. Gurruchaga; M. Vinti; G. Fenelon; P. Brugière; S. Kingsman; P. Hantraye; P. Remy; K. Mitrophanous; S. Palfl

Book ID: 117753759
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70556-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of Pro

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

✍ Palfi, Stéphane; Gurruchaga, Jean Marc; Ralph, G Scott; Lepetit, Helene; Lavisse 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 657 KB

Safety and tolerability of gene therapy

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

✍ Michael G Kaplitt; Andrew Feigin; Chengke Tang; Helen L Fitzsimons; Paul Mattis; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 247 KB

Safety profile, efficacy, and biodistrib

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma

✍ Puntel, Mariana; A.K.M., Ghulam Muhammad; Farrokhi, Catherine; VanderVeen, Natha 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 717 KB

Phase I/II Trial of Adeno-Associated Vir

Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes

✍ Smith, Barbara K.; Collins, Shelley W.; Conlon, Thomas J.; Mah, Cathryn S.; Laws 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 530 KB

RTOG 95-17, a Phase II trial to evaluate

RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma—year-5 toxicity and cosmesis

✍ Rabinovitch, Rachel; Winter, Kathryn; Kuske, Robert; Bolton, John; Arthur, Doug; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A phase I/II trial to evaluate the safet

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma – the STORM trial

✍ Mathias Witzens-Harig, Marie Luise Memmer, Martin Dreyling, Georg Hess 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 171 KB